Alkem Laboratories Stock Performance
as on June 8, 2026 at 4:03 pm IST
Day's Low
Day's High
₹5,175.50₹5,329.50
2.68%
Downside
0.22%
Upside

52 Week's Low
52 Week's High
₹4,716.20₹5,933.50
11.32%
Downside
11.57%
Upside

Alkem Laboratories share price movements today
- Previous Close
- ₹5,251.50
- Open
- ₹5,314.00
- Volume
- 33.84K
- Upper Circuit
- ₹5,776.50
- Lower Circuit
- ₹4,726.50
- Day's Low - High
- ₹5,175.50 - ₹5,329.50
- 52 Week Low - High
- ₹4,716.20 - ₹5,933.50
Alkem Laboratories Historical Returns
- 1 Month Return
- -5.98 %
- 3 Month Return
- -3.82 %
- 1 Year Return
- + 7.76 %
- 3 Year Return
- + 52.57 %
- 5 Year Return
- + 65.36 %
Alkem Laboratories Fundamentals
as on June 8, 2026 at 10:33 am IST
Market Cap
₹62,789.56 Cr
Return on Equity (ROE)
19.94
PE Ratio (TTM)
27.28
Return on capital employed (ROCE)
20.29
Industry PE ratio
46.11
Beta (LTM)
0.77
P/B Ratio
4.73
Dividend Yield
0.92
PEG Ratio
2.39
Quarterly Earnings Growth YOY
-22.08
EPS (TTM)
185.36
Book Value
1002.5
Alkem Laboratories Stock Valuation
as on June 8, 2026 at 10:33 am IST
Alkem Laboratories in the last 5 years
Lowest (20.07x)
March 24, 2021
Today (27.28x)
June 5, 2026
Industry (46.11x)
June 5, 2026
Highest (44.21x)
August 9, 2023
Today’s Price to Earnings Ratio: 27.28x
Alkem Laboratories Technical Analysis
Track how Alkem Laboratories technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 10.53 | |
CCI (20) | -265.57 | Bullish |
RSI (14) | 53.99 | Neutral |
Momentum (10) | -10 | |
ADI (14) | 51.77 | Bullish |
Ultimate Oscillator (7,14,28) | 72.79 | Bullish |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 5327.85 | |
EMA (20) | 5325.82 | |
VWMA (20) | 5331.55 | |
SMA (50) | 5299.49 | Bullish |
EMA (50) | 5301.85 | Bullish |
SMA (200) | 5256.69 | Bullish |
EMA (200) | 5266.74 | Bullish |
KAMA (200) | 5329.22 | |
DEMA (200) | 5278.13 | Bullish |
Alkem Laboratories Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Alkem Laboratories with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 62,789.56 | 13.07% | 0.59 | 2,216 | 12,964 | |
| BUY | 25,764.25 | 0.61% | 0.54 | 492 | 2,461 | |
| HOLD | 78,163.31 | 27.53% | 0.00 | 354 | 5,553 | |
| BUY | 14,121.55 | 24.26% | 0.65 | 143 | 704 | |
| BUY | 8,244.76 | 8.15% | 0.55 | 162 | 829 |
Market expectation of Alkem Laboratories Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
50.00%
Buy
33.33%
Hold
16.67%
Sell
Alkem Laboratories Stock’s Investor Sentiment and Interest
Search interest for Alkem Laboratories Ltd Stock has increased by 49% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:49% versus previous 30 day period
Alkem Laboratories Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Alkem Laboratories Ltd Annual Profit & Loss
Figures in Rupees Crores
Alkem Laboratories Ltd Cash Flow
Figures in Rupees Crores
Alkem Laboratories Corporate Actions
View detailed summary of the earnings and dividend history of Alkem Laboratories.
Alkem Laboratories Ltd Earnings Results
Alkem Laboratories Ltd’s net profit fell -22.69% since last year same period to ₹236.46Cr in the Q4 2025-2026. On a quarterly growth basis, Alkem Laboratories Ltd has generated -62.82% fall in its net profits since last 3-months.
Read More about Earnings ResultsAlkem Laboratories Ltd Dividends February,2026
In the quarter ending December 2025, Alkem Laboratories Ltd has declared dividend of ₹43.00 per share on 13 Feb 2026 - translating a dividend yield of 0.97%.
Read More about Dividends
Indices Featuring Alkem Laboratories Stock
Check stock indices that include Alkem Laboratories.
Insights on Alkem Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up

Foreign Institutions have increased holdings from 9.97% to 10.16% in Mar 2026 quarter
NO EFFECTAgainst Peers

In the last 3 years, Torrent Pharmaceuticals Ltd has given 145.9% return, outperforming this stock by 93.3%
NO EFFECTAgainst Peers

In the last 1 year, Torrent Pharmaceuticals Ltd has given 39.0% return, outperforming this stock by 31.2%
NO EFFECTPromoter Holding Unchanged

Promoters holdings remained unchanged at 51.20% of holdings in Mar 2026 quarter
NEGATIVE IMPACTMF Holding Down

Mutual Funds have decreased holdings from 16.06% to 15.57% in Mar 2026 quarter
NEGATIVE IMPACTPrice Dip

In the last 3 months, ALKEM stock has moved down by -3.8%
NEGATIVE IMPACTRetail Holding Down

Retail Investor have decreased holdings from 17.30% to 17.25% in Mar 2026 quarter
NEGATIVE IMPACTProfit Down

Netprofit is down for the last 3 quarters, 765.06 Cr → 236.46 Cr (in ₹), with an average decrease of 39.8% per quarter
NEGATIVE IMPACTRevenue Fall

Revenue is down for the last 3 quarters, 4.10K Cr → 3.80K Cr (in ₹), with an average decrease of 3.7% per quarter
Alkem Laboratories Stock Futures & Options Contracts
View the latest movement in Alkem Laboratories Futures & Options, including strike prices, expiry dates, and percentage changes.
Alkem Laboratories Options
Alkem Laboratories Futures
About Alkem Laboratories Ltd
With its headquarters in Mumbai, India, Alkem Laboratories is engaged in the manufacture of a wide range of pharmaceutical products across multiple therapeutic categories, including cardiovascular, central nervous system, gastro-intestinal, anti-infective, diabetology, and nutrition. The company has a strong presence in the Indian market and exports its products to over 50 countries.
Revenue: ₹3,603.32Cr as on March 2026 (Q4 FY26)
Net Profit: ₹251.68Cr as on March 2026 (Q4 FY26)
Listing date: 23 Dec, 2015
Chairperson Name: Basudeo N Singh
| Organisation | Alkem Laboratories Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Basudeo N Singh |
| E-voting on shares | Click here to vote |
FAQs
What is Alkem Laboratories share price today?
Alkem Laboratories share price today stands at ₹5318 as on . Alkem Laboratories share today touched a day high of ₹5329.5 and a low of ₹5175.5.
What is the 52 week high and 52 week low range for Alkem Laboratories share?
Alkem Laboratories touched a 52 week high of ₹5933.5 and a 52 week low of ₹4716.2. Alkem Laboratories share price today i.e. is trending at ₹5318, which is -10.37% down from its 52 week high and 12.76% up from its 52 week low.
What is Alkem Laboratories's market capitalisation today?
Alkem Laboratories market capitalisation is ₹62,789.56 Cr as on .
How to buy Alkem Laboratories shares?
To buy Alkem Laboratories shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for ALKEM or Alkem Laboratories Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Alkem Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Alkem Laboratories trading volume today?
Alkem Laboratories trading volume is 33.84K as on . This means that 33.84K shares of Alkem Laboratories were bought and sold on the stock market during today's trading session.